$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000114420417027370 Filed on May 15, 2017

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$4.914M	$4.238M
YoY Change	15.95%	2.94%
Cost Of Revenue	$2.568M	$2.505M
YoY Change	2.51%	-0.6%
Gross Profit	$2.346M	$1.733M
YoY Change	35.37%	8.52%
Gross Profit Margin	47.74%	40.89%
Selling, General & Admin	$1.139M	$949.0K
YoY Change	20.02%	15.59%
% of Gross Profit	48.55%	54.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.622M	$1.574M
YoY Change	3.05%	3.76%
% of Gross Profit	69.14%	90.83%
Operating Expenses	$1.139M	$949.0K
YoY Change	20.02%	15.59%
Operating Profit	$754.0K	$499.0K
YoY Change	51.1%	9.43%
Interest Expense	$453.0K	$285.0K
YoY Change	58.95%	-10.94%
% of Operating Profit	60.08%	57.11%
Other Income/Expense, Net
YoY Change
Pretax Income	$758.0K	$396.0K
YoY Change	91.41%	-14.29%
Income Tax	$216.0K	$64.00K
% Of Pretax Income	28.5%	16.16%
Net Earnings	$293.0K	$51.00K
YoY Change	474.51%	-60.16%
Net Earnings / Revenue	5.96%	1.2%
Basic Earnings Per Share	$0.05	$0.01
Diluted Earnings Per Share	$0.05	$0.01
COMMON SHARES
Basic Shares Outstanding	5.685M shares	5.541M shares
Diluted Shares Outstanding	5.884M shares	5.541M shares

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.400M	$2.140M
YoY Change	12.15%	130.11%
Cash & Equivalents	$2.403M	$2.140M
Short-Term Investments
Other Short-Term Assets	$1.230M	$580.0K
YoY Change	112.07%	-33.33%
Inventory
Prepaid Expenses
Receivables	$4.881M	$3.557M
Other Receivables	$249.0K	$88.00K
Total Short-Term Assets	$8.765M	$6.366M
YoY Change	37.68%	8.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.83M	$52.76M
YoY Change	-3.67%	5.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$579.0K	$579.0K
YoY Change	0.0%	-78.63%
Other Assets	$260.0K	$382.0K
YoY Change	-31.94%	-26.11%
Total Long-Term Assets	$51.67M	$53.72M
YoY Change	-3.83%	1.18%
TOTAL ASSETS
Total Short-Term Assets	$8.765M	$6.366M
Total Long-Term Assets	$51.67M	$53.72M
Total Assets	$60.43M	$60.09M
YoY Change	0.57%	1.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$437.0K	$531.0K
YoY Change	-17.7%	76.41%
Accrued Expenses	$1.300M	$1.250M
YoY Change	4.0%	0.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.710M	$2.637M
YoY Change	154.46%	30.8%
Total Short-Term Liabilities	$8.438M	$9.185M
YoY Change	-8.13%	21.13%
LONG-TERM LIABILITIES
Long-Term Debt	$19.29M	$21.26M
YoY Change	-9.27%	3.15%
Other Long-Term Liabilities	$580.0K	$690.0K
YoY Change	-15.94%	-19.77%
Total Long-Term Liabilities	$19.87M	$21.95M
YoY Change	-9.48%	2.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.438M	$9.185M
Total Long-Term Liabilities	$19.87M	$21.95M
Total Liabilities	$38.48M	$39.85M
YoY Change	-3.44%	290.61%
SHAREHOLDERS EQUITY
Retained Earnings	$5.243M	$4.071M
YoY Change	28.79%	-28.2%
Common Stock	$16.71M	$16.17M
YoY Change	3.35%	1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.95M	$20.24M
YoY Change
Total Liabilities & Shareholders Equity	$60.43M	$60.09M
YoY Change	0.58%	1.92%

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	$293.0K	$51.00K
YoY Change	474.51%	-60.16%
Depreciation, Depletion And Amortization	$1.622M	$1.574M
YoY Change	3.05%	3.76%
Cash From Operating Activities	$1.649M	$1.720M
YoY Change	-4.13%	29.32%
INVESTING ACTIVITIES
Capital Expenditures	$114.0K	$333.0K
YoY Change	-65.77%	77.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$114.0K	-$330.0K
YoY Change	-65.45%	73.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$495.0K	$1.439M
YoY Change	-65.6%	258.85%
Cash From Financing Activities	-$2.003M	-1.460M
YoY Change	37.19%	14.96%
NET CHANGE
Cash From Operating Activities	$1.649M	1.720M
Cash From Investing Activities	-$114.0K	-330.0K
Cash From Financing Activities	-$2.003M	-1.460M
Net Change In Cash	-$468.0K	-70.00K
YoY Change	568.57%	-46.15%
FREE CASH FLOW
Cash From Operating Activities	$1.649M	$1.720M
Capital Expenditures	$114.0K	$333.0K
Free Cash Flow	$1.535M	$1.387M
YoY Change	10.67%	21.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	499000	USD
CY2016Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	5000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	396000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	332000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	281000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	51000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60433000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1100000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1103000	USD
CY2017Q1	us-gaap	Assets Assets	60433000	USD
CY2017Q1	us-gaap	Equity Method Investments EquityMethodInvestments	579000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	579000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	949000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	285000	USD
CY2016Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	244000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	1733000	USD
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1139000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	453000	USD
CY2017Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	232000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	2346000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	754000	USD
CY2017Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	542000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	249000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	293000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-108000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	60000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1720000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1649000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1574000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1622000	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	64000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	174000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	59000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	50000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	500000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	755000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1439000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	495000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5949000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27774000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27173000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8438000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8681000	USD
CY2017Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	5597000	USD
CY2016Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	5106000	USD
CY2017Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	13691000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	14852000	USD
CY2017Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	583000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	610000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4350000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4176000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	10711000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	10596000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5999000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5243000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	5678000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60598000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2403000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2871000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	5821000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	21495000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	21953000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4950000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	250000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	250000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4881000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4085000	USD
CY2017Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	249000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	4873000	USD
CY2017Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	4490000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	184000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	193000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	319000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	437000	USD
CY2016Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	290000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	982000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	892000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	8765000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	8388000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	758000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	216000	USD
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1562000	USD
CY2016Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	699000	USD
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1604000	USD
CY2017Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	732000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1064000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1517000	USD
CY2017Q1	us-gaap	Cost Method Investments CostMethodInvestments	579	USD
CY2017Q1	ams	Assets Carrying Value AssetsCarryingValue	3232	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5468000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5706000	shares
CY2016Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	97000	USD
CY2017Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	106000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-69000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-468000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2209000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2140000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	333000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1106000	USD
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4000	USD
CY2017Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1106000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-333000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1011000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1456000	USD
CY2017Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2016Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7000	USD
CY2017Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2016Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000	USD
CY2017Q1	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	0	USD
CY2016Q1	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	1137000	USD
CY2017Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	98490000	USD
CY2016Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	96270000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	537000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	537000	USD
CY2017Q1	ams	Deposits And Construction In Progress Gross DepositsAndConstructionInProgressGross	6959000	USD
CY2016Q4	ams	Deposits And Construction In Progress Gross DepositsAndConstructionInProgressGross	8073000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105986000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	104880000	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	55160000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	53549000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50826000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51331000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5706000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5468000	shares
CY2017Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4914000	USD
CY2016Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4238000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	2568000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	2505000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25180000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	215000	USD
CY2016	ams	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	220000	USD
CY2016	ams	Investment In Subsidiaries By Noncontrolling Interests InvestmentInSubsidiariesByNoncontrollingInterests	7000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	699000	USD
CY2017Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	106000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	2250000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	50000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	115000	USD
CY2017Q1	ams	Net Accrued Interest On Lease Financing NetAccruedInterestOnLeaseFinancing	27000	USD
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	199000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5884000	shares
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	-78000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	134000	USD
CY2016Q1	ams	Net Accrued Interest On Lease Financing NetAccruedInterestOnLeaseFinancing	0	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	-31000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	136000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	491000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	515000	USD
CY2017Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	22000	USD
CY2016Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	96000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2016Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6870000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5685000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5541000	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5541000	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	617000	shares
CY2008Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000	shares
CY2017Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	72000	shares
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2653	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3121	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	579	USD
CY2016Q4	ams	Assets Carrying Value AssetsCarryingValue	3700	USD
CY2017Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	7812	USD
CY2016Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	7311	USD
CY2017Q1	ams	Liabilities Carrying Value LiabilitiesCarryingValue	7812	USD
CY2016Q4	ams	Liabilities Carrying Value LiabilitiesCarryingValue	7311	USD
CY2017Q1	ams	Restricted Cash And Cash Equivalents Fair Value RestrictedCashAndCashEquivalentsFairValue	2653	USD
CY2016Q4	ams	Restricted Cash And Cash Equivalents Fair Value RestrictedCashAndCashEquivalentsFairValue	3121	USD
CY2017Q1	us-gaap	Cost Method Investments Fair Value Disclosure CostMethodInvestmentsFairValueDisclosure	579	USD
CY2016Q4	us-gaap	Cost Method Investments Fair Value Disclosure CostMethodInvestmentsFairValueDisclosure	579	USD
CY2017Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3232	USD
CY2016Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3700	USD
CY2017Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	7040	USD
CY2016Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	7354	USD
CY2017Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7040	USD
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7354	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	100000	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.20
CY2017Q1	ams	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	100000	shares
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	AMERICAN SHARED HOSPITAL SERVICES
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000744825
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2017Q1	dei	Trading Symbol TradingSymbol	AMS
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5707000	shares
CY2017Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	115000	USD
CY2016Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	59000	USD
CY2017Q1	ams	Warrants Issued With Cashless Exercise During Period WarrantsIssuedWithCashlessExerciseDuringPeriod	25000	shares
CY2017Q1	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	992000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	0	USD

Files In Submission

Name	View Source	Status
0001144204-17-027370-index-headers.html	Edgar Link	pending
0001144204-17-027370-index.html	Edgar Link	pending
0001144204-17-027370.txt	Edgar Link	pending
0001144204-17-027370-xbrl.zip	Edgar Link	pending
ams-20170331.xml	Edgar Link	completed
ams-20170331.xsd	Edgar Link	pending
ams-20170331_cal.xml	Edgar Link	unprocessable
ams-20170331_def.xml	Edgar Link	unprocessable
ams-20170331_lab.xml	Edgar Link	unprocessable
ams-20170331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pg01img01_ex3-1.jpg	Edgar Link	pending
pg02img01_ex3-1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v466285_10q.htm	Edgar Link	pending
v466285_ex10-1.htm	Edgar Link	pending
v466285_ex3-1.htm	Edgar Link	pending
v466285_ex3-2.htm	Edgar Link	pending
v466285_ex31-1.htm	Edgar Link	pending
v466285_ex31-2.htm	Edgar Link	pending
v466285_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2017 Q1 Form 10-Q Financial Statement

#000114420417027370 Filed on May 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2017 Q1 Form 10-Q Financial Statement

#000114420417027370 Filed on May 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams